Two types of imported tumor medication risk Stake Sports Bettingstake online sports bettingdrug supervision bureau ordered to stop sales
Release time: 2011-12-09 & nbsp & nbsp & nbsp Source:
Business Club, December 9th News
China's official on the 8th requires Chinese agents to take measures to control the risks of the two imported tumors "Kai Lai" and "Wan Ke"。
The National Food and Drug Administration requires the same day，Agent imported Ben Venus Laboratories (referred to as "BVL Company").，Immediately take the initiative to recall Kailai of all batch numbers in the market，Stop selling Wanke immediately，No longer used in new patients。
The Drug Administration also requires an effective way to inform the doctors and patients that may exist.，For Stake Sports Bettingpatients who are using Kailai，It is recommended Stake Sports Bettingto use other similar medicines，For patients who are using Wanke，It should be negotiated with doctors and patients，When the patient knows and agree,，Fang can continue to use，Register for medication。
According to the announcement of the European Drug Administration，UK、France and the United States regulatory agency conducted a joint GMP inspection on BVL's production sites in the United States in November this year，It is found that the quality management of its sterile irrigation process is defective。China immediately evaluated the risks that BVL produced in the Mainland to produce in the Mainland.。
Kailai (General name "Pharine Hydrochloride Bybolic Body Injection") is used to treat AIDS -related Kaboa sarcoma，There are still two companies stake online sports bettingstake betting appin registered manufacturers in China，Wan Ke (the general name "injection for boronomi") is used to treat multiple osteoma and suite lymphoma，Only BVL companies registered in China，There are no other similar alternative drugs in clinical practice。The above two medicines are clinically necessary medicines。(Reporter Ouyang Kaiyu)
China's official on the 8th requires Chinese agents to take measures to control the risks of the two imported tumors "Kai Lai" and "Wan Ke"。
The National Food and Drug Administration requires the same day，Agent imported Ben Venus Laboratories (referred to as "BVL Company").，Immediately take the initiative to recall Kailai of all batch numbers in the market，Stop selling Wanke immediately，No longer used in new patients。
The Drug Administration also requires an effective way to inform the doctors and patients that may exist.，For Stake Sports Bettingpatients who are using Kailai，It is recommended Stake Sports Bettingto use other similar medicines，For patients who are using Wanke，It should be negotiated with doctors and patients，When the patient knows and agree,，Fang can continue to use，Register for medication。
According to the announcement of the European Drug Administration，UK、France and the United States regulatory agency conducted a joint GMP inspection on BVL's production sites in the United States in November this year，It is found that the quality management of its sterile irrigation process is defective。China immediately evaluated the risks that BVL produced in the Mainland to produce in the Mainland.。
Kailai (General name "Pharine Hydrochloride Bybolic Body Injection") is used to treat AIDS -related Kaboa sarcoma，There are still two companies stake online sports bettingstake betting appin registered manufacturers in China，Wan Ke (the general name "injection for boronomi") is used to treat multiple osteoma and suite lymphoma，Only BVL companies registered in China，There are no other similar alternative drugs in clinical practice。The above two medicines are clinically necessary medicines。(Reporter Ouyang Kaiyu)
